About the course
Are you a parent or clinician seeking evidence-based strategies for treating mitochondrial dysfunction and its impact on neurodevelopmental disorders such as Autism Spectrum Disorder (ASD)? This on-demand course offers a unique opportunity to learn directly from Richard E. Frye, MD, PhD, a child neurologist and leading researcher who has spent decades studying metabolic and mitochondrial dysfunction in ASD. This course covers clinical approaches to diagnosis, emerging therapies, and practical treatment strategies to support patients with mitochondrial dysfunction.
About the Creator
Dr. Richard Frye is a Child Neurologist specializing in neurodevelopmental and neurometabolic disorders. He holds an MD and PhD from Georgetown University, completed residencies and fellowships at Harvard and Boston University, and is board-certified in Pediatrics and Neurology with Special Competence in Child Neurology. A national leader in autism research, Dr. Frye has authored over 300 peer-reviewed publications and led multiple clinical trials investigating metabolic and physiological treatments for ASD, including folinic acid. His current research focuses on metabolic endophenotypes and targeted therapies for ASD. In 2022, he co-founded The Autism Discovery and Treatment Foundation and continues to see patients in the U.S. and internationally.